Dudediligence.

Biogen Inc

BIIBNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Jul 2910-QQuarterly report
  2. Jul 298-KResults of operations2.029.01
  3. Jul 18-KResults of operations2.02
  4. Jun 108-KShareholder vote5.07
  5. Jun 108-K/AFinancial statements and exhibits (amended)9.01
  6. May 148-KMaterial agreement and acquisition or sale of assets completed1.012.012.037.019.01
  7. Apr 2910-QQuarterly report
  8. Apr 298-KResults of operations2.029.01
  9. Apr 68-KResults of operations2.02
  10. Mar 318-KMaterial agreement and other events1.018.019.01
  11. Mar 118-KOfficer or director change5.02
  12. Feb 118-KOfficer or director change and other events5.028.01
  13. Feb 610-KAnnual report
  14. Feb 68-KResults of operations2.029.01
  15. Jan 138-KResults of operations2.02
  16. Oct 30, 202510-QQuarterly report
  17. Oct 30, 20258-KResults of operations2.029.01
  18. Oct 14, 20258-KResults of operations2.029.01
  19. Jul 31, 20258-KResults of operations2.029.01
  20. Jul 31, 202510-QQuarterly report
  21. Jul 7, 20258-KResults of operations2.029.01
  22. Jun 23, 20258-KShareholder vote5.079.01
  23. May 12, 20258-KOther events8.019.01
  24. May 8, 2025424B2Prospectus for an offering
  25. May 6, 2025424B2Prospectus for an offering
  26. May 1, 202510-QQuarterly report
  27. May 1, 20258-KResults of operations2.029.01
  28. Feb 12, 202510-KAnnual report
  29. Feb 12, 20258-KResults of operations2.029.01
  30. Jan 15, 20258-KOfficer or director change5.02
  31. Oct 30, 20248-KOfficer or director change and Regulation FD disclosure5.027.019.01
  32. Oct 30, 202410-QQuarterly report
  33. Oct 30, 20248-KResults of operations2.029.01